Sort
23,748 grants matching “melanoma”
Functional genomic analysis of neural crest development
$958,484William J Pavan · National Human Genome Research Institute · ZIA · FY2019 · HG
Phase 1 cross over biodistribution study of [203Pb]VMT01 for single photon emission computed tomography (SPECT) and [68Ga]VMT02 for positron emission tomography (PET) imaging of stage 4 melanoma
$958,108Frances L Johnson · Viewpoint Molecular Targeting, Inc. · R44 · FY2019 · CA
Determining the Fate of Transmembrane Proteins
$957,415Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Genetic Epidemiology of Cancer
$957,336Joan E. Bailey-Wilson · Human Genome Research · Z01 · FY2007 · HG
Role of Tumor Stroma in Therapeutic Response and Resistance
$954,554Lynda Chin · University Of Tx Md Anderson Can Ctr · U54 · FY2013 · CA
Tumor Microenvironment in Cancer Progression
$954,297Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Non-invasive staging of Metastasis by Precision MRI
$954,220Jenny J Yang · Inlighta Biosciences, Llc · R44 · FY2022 · CA
Molecular Pathogenesis of Neoplasia
$953,971John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Integrated, Individualized, Intelligent Prescribing (I3P)
$953,342Joshua C. Denny · Vanderbilt University · U01 · FY2015 · HG
Characterization Unit
$952,082David Liu · Dana-Farber Cancer Inst · U2C · FY2022 · CA
Characterization Unit
$952,082Orit Rozenblatt-Rosen · Dana-Farber Cancer Inst · U2C · FY2020 · CA
Characterization Unit
$952,082Orit Rozenblatt-Rosen · Dana-Farber Cancer Inst · U2C · FY2019 · CA
Molecular and immunologic evolution of melanomas from pre-neoplastic lesions
$951,000Boris C Bastian · University Of California, San Francisco · R35 · FY2021 · CA
Molecular and immunologic evolution of melanomas from pre-neoplastic lesions
$951,000Boris C Bastian · University Of California, San Francisco · R35 · FY2018 · CA
Molecular and immunologic evolution of melanomas from pre-neoplastic lesions
$951,000Boris C Bastian · University Of California, San Francisco · R35 · FY2020 · CA
DEVELOPMENT OF AN ELECTRICAL DIAGNOSTIC FOR MELANOMA
$950,437Richard Lee Nuccitelli · Bioelectromed Corporation · R44 · FY2007 · CA
Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors
$950,045Rosa Maria Diaz · Vyriad, Inc. · R44 · FY2019 · CA
Regulation of Ras-Dependent Signal Transduction Pathways
$949,747Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Characterization Unit
$949,009Alex K Shalek · Dana-Farber Cancer Inst · U2C · FY2018 · CA
A MODEL FOR GENETIC SUSCEPTIBILITY: MELANOMA
$948,410University Of New Mexico · U01 · FY2003 · CA
Combining receptor-targeted alpha particle therapy and immunotherapy to achieve complete responses in metastatic melanoma
$948,099Michael King Schultz · Viewpoint Molecular Targeting, Inc. · R44 · FY2023 · CA
Center for Cancer Immunology and Immunotherapy (CCII).
$947,067Jun Yan · University Of Louisville · P20 · FY2024 · GM
TARGETING LIGAND-DEPENDENT BMP SIGNALING IN MELANOMA. NEW AWARD.
$946,940University Of Massachusetts Medical School · · FY2020 · Defense Health Agency
Mechanisms of impaired T-cell mechanosensing of melanoma antigens
$946,295Cheng Zhu · Georgia Institute Of Technology · U01 · FY2020 · CA
Overcoming resistance to anti-PD1 immunotherapy
$946,072Thomas F Gajewski · University Of Chicago · R35 · FY2020 · CA